Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Handbook of Experimental Pharmacology
|
October 23, 2015
Predictive In Vivo Models for Oncology
Diana Behrens, Jana Rolff, Jens Hoffmann
Journal of Oncology
|
June 24, 2009
[Not Available]
Jana Rolff, Cornelia Dorn, Johannes Merk, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
June 9, 2009
Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
Johannes Merk, Jana Rolff, Michael Becker, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
March 23, 2011
Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
Johannes Merk, Jana Rolff, Cornelia Dorn, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 10, 2015
Investigation of cell culture volatilomes using solid phase micro extraction: Options and pitfalls exemplified with adenocarcinoma cell lines
Kristin Schallschmidt, Roland Becker, Christian Jung, et al.
Scientific Reports
|
April 12, 2018
GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway
Susann Kleinsimon, Enya Longmuss, Jana Rolff, et al.
Plos One
|
September 3, 2016
Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma
Monika Twardziok, Susann Kleinsimon, Jana Rolff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer
Stefanie Hammer, Anette Sommer, Iduna Fichtner, et al.
Journal of Immunology Research
|
August 10, 2017
Synergistic Antitumour Properties of <i>viscumTT</i> in Alveolar Rhabdomyosarcoma
Rahel Mascha Stammer, Susann Kleinsimon, Jana Rolff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers
Iduna Fichtner, Jana Rolff, Richie Soong, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Handbook of Experimental Pharmacology
|
October 23, 2015
Predictive In Vivo Models for Oncology
Diana Behrens, Jana Rolff, Jens Hoffmann
Journal of Oncology
|
June 24, 2009
[Not Available]
Jana Rolff, Cornelia Dorn, Johannes Merk, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
June 9, 2009
Patient-derived xenografts of non-small-cell lung cancer: a pre-clinical model to evaluate adjuvant chemotherapy?
Johannes Merk, Jana Rolff, Michael Becker, et al.
European Journal of Cardio-Thoracic Surgery : Official Journal of the European Association for Cardio-Thoracic Surgery
|
March 23, 2011
Chemoresistance in non-small-cell lung cancer: can multidrug resistance markers predict the response of xenograft lung cancer models to chemotherapy?
Johannes Merk, Jana Rolff, Cornelia Dorn, et al.
Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences
|
November 10, 2015
Investigation of cell culture volatilomes using solid phase micro extraction: Options and pitfalls exemplified with adenocarcinoma cell lines
Kristin Schallschmidt, Roland Becker, Christian Jung, et al.
Scientific Reports
|
April 12, 2018
GADD45A and CDKN1A are involved in apoptosis and cell cycle modulatory effects of viscumTT with further inactivation of the STAT3 pathway
Susann Kleinsimon, Enya Longmuss, Jana Rolff, et al.
Plos One
|
September 3, 2016
Multiple Active Compounds from Viscum album L. Synergistically Converge to Promote Apoptosis in Ewing Sarcoma
Monika Twardziok, Susann Kleinsimon, Jana Rolff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 25, 2010
Comparative profiling of the novel epothilone, sagopilone, in xenografts derived from primary non-small cell lung cancer
Stefanie Hammer, Anette Sommer, Iduna Fichtner, et al.
Journal of Immunology Research
|
August 10, 2017
Synergistic Antitumour Properties of <i>viscumTT</i> in Alveolar Rhabdomyosarcoma
Rahel Mascha Stammer, Susann Kleinsimon, Jana Rolff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 18, 2008
Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers
Iduna Fichtner, Jana Rolff, Richie Soong, et al.
Page
of 3